Cytokinetics
CYTK
#2280
Rank
ยฃ6.02 B
Marketcap
ยฃ49.30
Share price
-1.31%
Change (1 day)
24.80%
Change (1 year)

Revenue for Cytokinetics (CYTK)

Revenue in 2025 (TTM): ยฃ64.77 Million

According to Cytokinetics 's latest financial reports the company's current revenue (TTM ) is ยฃ65.46 Million. In 2024 the company made a revenue of ยฃ14.72 Million an increase over the revenue in the year 2023 that were of ยฃ5.91 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cytokinetics from 2003 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ64.77 M340.03%
2024 ยฃ14.72 M149.07%
2023 ยฃ5.91 M-92.44%
2022 ยฃ78.18 M49.85%
2021 ยฃ52.17 M27.39%
2020 ยฃ40.95 M99.9%
2019 ยฃ20.48 M-17.44%
2018 ยฃ24.81 M150.9%
2017 ยฃ9.89 M-88.53%
2016 ยฃ86.23 M345.93%
2015 ยฃ19.33 M-35.86%
2014 ยฃ30.14 M62.27%
2013 ยฃ18.58 M297.29%
2012 ยฃ4.67 M81.73%
2011 ยฃ2.57 M54.22%
2010 ยฃ1.66 M-96.69%
2009 ยฃ50.38 M494.59%
2008 ยฃ8.47 M23.59%
2007 ยฃ6.85 M329.52%
2006 ยฃ1.59 M-69.11%
2005 ยฃ5.16 M-26.19%
2004 ยฃ7 M18.26%
2003 ยฃ5.92 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ligand Pharmaceuticals
LGND
ยฃ0.18 B 188.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
ยฃ0.4 M-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
ยฃ86.82 M 32.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ27.00 B 41,145.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
ยฃ1.00 B 1,428.85%๐Ÿ‡บ๐Ÿ‡ธ USA